chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About one week after receiving my second dose in my right deltoid, I developed an itchy raised rash on my left upper arm outer elbow area that persists even today. I received my first dose in my left arm on January 5th. This rash is very reminiscent of the type of reaction I have had when I have been in contact with Mangos (which I am allergic to). I can't think of anything else that was different in my life that could explain this.
A day after getting the vaccine, had fatigue, body ache, headache, fever of 101, sore throat, bitter taste, dizziness.
Atrial fibrillation; Daily itching; Flaky skin; This is a spontaneous report received from a contactable consumer (patient) based on information received by Pfizer. (Manufacturer Control Number 20210823000368). A patient of unspecified age and gender received bnt162b2 (BNT162B2), via an unspecified route of administration on 19Jan2021 (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced atrial fibrillation (caused hospitalization) on 10Mar2021 with outcome of unknown, daily itching (non-serious) on 2021 with outcome of recovering, flaky skin (non-serious) on 2021 with outcome of recovering. Therapeutic measures were taken as a result of the events and included treatment with cardioversion and long-term use of medications (for atrial fibrillation), Dupixent (for daily itching and flaky skin).  The lot number for bnt162b2 was not provided and will be requested during follow-up.
Experienced normal side effects within first 24 hours (fever 100.4, body aches, headache, fatigue). Those side effects went away within a day. However, 5 days after vaccination I awoke with dizziness and fatigue. The dizziness was strong enough that I was unable to work and spent the day sleeping. I contacted my doctor and went in for a visit the next Day. No cause for the dizziness and fatigue was determined, but up one further reflection it is possible that it was a vaccine side effect which is why I?m reporting it here. The dizziness and fatigue was better the next day and completely gone two days later.
I was fine the day of the vaccine. When I woke up the next day I felt like I had a severe case of the Flu.  I had severe body aches, headache, muscle weakness, worse cough, injection site pain and swelling, chills, weakness/tiredness,  I felt like I had been hit by a car. I just tried to sleep and drink Gator Aid. The second day out from vaccination I felt much better. Just slight headache, body aches,  weakness.  My injection site started to hurt later in the second day. It still hurts today-seven days out from administration.
Concerned with employee underwent Hepatitis B vaccination series x2. 3 vaccinations each series vaccinations were pediatric doses x2 for adult dosing. Each vaccination was a different lot number, however same pediatric dose lot numbers at the vaccination dates. Hepatitis B surface antibody titer checks after both series (-) negative immunity response.
got bad shortness or breath; high heart rate; felt faint while driving; didn't feel good at all; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (got bad shortness or breath), HEART RATE INCREASED (high heart rate), DIZZINESS (felt faint while driving) and FEELING ABNORMAL (didn't feel good at all) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Depression. Concomitant products included ESCITALOPRAM for Depression.    On 29-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Nov-2021, the patient experienced DYSPNOEA (got bad shortness or breath), HEART RATE INCREASED (high heart rate), DIZZINESS (felt faint while driving) and FEELING ABNORMAL (didn't feel good at all). At the time of the report, DYSPNOEA (got bad shortness or breath), HEART RATE INCREASED (high heart rate), DIZZINESS (felt faint while driving) and FEELING ABNORMAL (didn't feel good at all) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Nov-2021, Heart rate: high (High) high heart rate.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Treatment medication was reported. Patient reported that, the events lasted almost 45 minutes. Reporter stated that On 03 Nov 2021 while walking to class, patient experienced shortness of breath again. Also reported that, patient was not going to get the second Moderna shot.
The first shot I did not have any issues. The second shot is my issue, I did not take any pain pills or have any other symptoms. For the 2 weeks after my second shot I could not pick up a skillet or open anything. I had no strength in my arm. I am not able to strengthen  my arm out without pain. This pain goes from where the shot was given down (inner arm area) pass my elbow. I went back to pharmacy & spoke to the pharmacy & the person that issued me the shot & explained what was going  on. He had no knowledge of this side effect. He at that point gave me V-safe to enroll in. It has been 3 weeks since the 2nd dose & I am still not able to fully extend my arm or pick up anything with weight (even my purse). Was a vein damaged or did he not administered it into the muscle, I need answers. Please advise what I need to do to get motion in my arm.
COVID-19; Upper respiratory infection; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), UPPER RESPIRATORY TRACT INFECTION (Upper respiratory infection) and FATIGUE (Fatigue) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    Concurrent medical conditions included Plaque psoriasis.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. In March 2021, the patient experienced FATIGUE (Fatigue). On an unknown date, the patient experienced COVID-19 (COVID-19) and UPPER RESPIRATORY TRACT INFECTION (Upper respiratory infection). At the time of the report, COVID-19 (COVID-19), UPPER RESPIRATORY TRACT INFECTION (Upper respiratory infection) and FATIGUE (Fatigue) outcome was unknown.            No concomitant medications were reported.   It was unknown if patient was enrolled in a COVID-19 vaccine trial. It was reported that the patient had two upper respiratory infections. He had COVID. In Mar-2021 he experienced fatigue followed by his Covid vaccine.  The reporter's causality for the event(s) of covid and fatigue was not provided. The reporter's causality for the event of upper respiratory infections with Skyrizi (risankizumab) was a reasonable possibility.  No treatment details were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
side effect; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effect) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effect). At the time of the report, VACCINATION COMPLICATION (side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   No treatment information was provided.
15 cm size area extending from injection site to elbow. Symptoms: Erythema Multiform, Urticaria Pruritus and tenderness. Treatment: Doxycycline 100 mg BID.
Cold in my arm when injected; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE COLDNESS (Cold in my arm when injected) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE COLDNESS (Cold in my arm when injected). At the time of the report, VACCINATION SITE COLDNESS (Cold in my arm when injected) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment related information has been reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
red spot; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (red spot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (red spot). At the time of the report, RASH MACULAR (red spot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information provided.
administered only the liquid adjuvant; administered only the liquid adjuvant; This case was reported by a pharmacist via a representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as the age at vaccination was not reported. The pharmacist reported that a nurse in a neighboring facility administered only the liquid adjuvant component of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter did not consent to follow up.
This spontaneous report was received from a registered nurse and refers to a 10 year old female patient. The patient's concurrent conditions, medical history and concomitant therapies were not reported. The stock of vaccine was received in summer 2017. On 08-NOV-2016, the patient was vaccinated with an improperly stored dose of VARIVAX, lot # L016124 with expiration date of 06-MAY-2017 (dose, route and frequency were not reported) for prophylaxis. It was stated that the vaccine underwent a temperature excursion of 6 degrees Fahrenheit to 14 degrees Fahrenheit for 42 days. It was reported that there was no need to repeat vaccine. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1705USA014053:
Projectile emesis; diarrhea; numbness in right (non vaccinated) arm; weakness-inability to walk; dizziness; some inability to talk or understand; vision problems; ringing in ears.
I experienced temporary partial vision loss.  For about 5 minutes, I had a blind spot of about 5 letters as I would read text on a computer screen.  As I would read across, the blind spot moved across the words of the screen.  After that cleared up, I noticed vision loss out of my right eye's right side peripheral for about another 5 minutes.  Then everything went back to normal.
Pt called Saturday morning to inform me that after receiving Flu vaccine Friday she felt very sick that evening & throughout night. She said swollen lips/neck, vomiting, chills, she didn't go to hospital and was fine by Saturday. She never received H1N1 before.
0815 Flu vaccine administered. 1100 itchy raised hives to torso, bilateral arms, neck. Eyes swollen, red, draining.
Infected at the injection; Nauseous; Thrown up; Bruises where the lump was; Spots all over where the lump was; Hard, not hot, knot; Red in a circle around where it swelled up; Swelled up, swelling started to go down; Hurt a little bit, but was nothing bad; 1st dose on 24-Apr-2021 and 2nd dose on 24-Jun-2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 24-Apr-2021 and 2nd dose on 24-Jun-2021), INDURATION (Hard, not hot, knot), ERYTHEMA (Red in a circle around where it swelled up), SWELLING (Swelled up, swelling started to go down) and PAIN (Hurt a little bit, but was nothing bad) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017C21A and 002C12A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 24-Apr-2021 and 2nd dose on 24-Jun-2021), ERYTHEMA (Red in a circle around where it swelled up), SWELLING (Swelled up, swelling started to go down) and PAIN (Hurt a little bit, but was nothing bad). On 25-Jun-2021, the patient experienced INDURATION (Hard, not hot, knot). On 26-Jun-2021, the patient experienced CONTUSION (Bruises where the lump was), RASH MACULAR (Spots all over where the lump was), NAUSEA (Nauseous) and VOMITING (Thrown up). On an unknown date, the patient experienced VACCINATION SITE INFECTION (Infected at the injection). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 24-Apr-2021 and 2nd dose on 24-Jun-2021), INDURATION (Hard, not hot, knot), ERYTHEMA (Red in a circle around where it swelled up), SWELLING (Swelled up, swelling started to go down), PAIN (Hurt a little bit, but was nothing bad), CONTUSION (Bruises where the lump was), RASH MACULAR (Spots all over where the lump was), VACCINATION SITE INFECTION (Infected at the injection), NAUSEA (Nauseous) and VOMITING (Thrown up) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product use was provided by the reporter.  Treatment medication included She had been using ice on the area and taking an antihistamine.
On day three, explosive diarrhea  with no effective remedy for two weeks that stopped literally overnight.
Patient immediately passed out after administration of second vaccine which was Moderna's monovalent vaccine, after Flu administration. Patient stopped breathing and was provided epinephrine 0.3 LOT G230106 EXP Date 8/31/2024 NDC 00115-1694-49 .Patient came to and was completely coherent within 2 minutes of passing out.
Information has been received from a registered nurse concerning a 19 year old female patient who was vaccinated with all three doses of GARDASIL when she was 18 years old. After the third dose of the series, the patient developed an allergy to chicken. The reporter also stated that the patient developed muscle getting hard at the injection site, and it was still hard. The patient did not receive GARDASIL at this office and received it in another state. At the time of reporting, the outcome was unknown. The patient sought unspecified medical attention. No further information is available.
Dermatitis of unknown etiology.  Initial distribution is like zoster; however, lesions are not characteristic of that.  No adenopathy or adjacent lesions.  Treat with Medrick Dosepak and refer to dermatology.
2/7/2021 031L20A 3/7/2021 031M0A 10/27/2021 939905 5/19/2022 038A22A 9/23/2022 AS7163B Moderna BiValent 6/17/2023 - 6/19/2023 (2 days) Presents to the emergency department for shortness of breath dexamethasone and remdesivir.
Tongue Paresthesia: 5 min later and dizziness half hour later. All sxs resolved in 3-4 hours.
Pt recv vax on 9/2/98; 15-30 sec later pt exp dizziness, nausea, immobile Rt arm, disoriented; dx=simple fainting anxiety due to injection
pt recv vax 12FEB97 & fever Tuesday & Wednesday;fever of 103 on 16FEB97 came to ER;also had runny nose & cough;
12-7-19 Extreme dizziness @ 4AM - walking to bathroom Nauseated slept a lot very sore arm joints & muscles achey during day missed family member funeral 12-8-19 sore neck w/a lump on left side of neck 12-10-13 - left upper arm itchey all week - food tastes very diff.
PNEUMONIA; INTESTINAL ISSUES; BRAIN FOG; NERVE PAIN; MUSCLE WEAKNESS; This spontaneous report received from a consumer via a company representative via social media concerned a female of an unspecified age, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, and expiry: unknown) dose, frequency time was 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient had brain fog, muscle weakness, and breathing problems. She also developed pneumonia, intestinal issues, and nerve pain. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the brain fog, muscle weakness, pneumonia, intestinal issues, and nerve pain was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: 20210957410-COVID-19 VACCINE AD26.COV2.S - Pneumonia. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Napped to 130p then awoke, inconsolable, swelling and tenderness at injection sites. Reseen in office at 345p. TYLENOL given and observed for 30 minutes.
Information has been received from a physician who is the father of a female who at 15 months of age was vaccinated SC with a dose of varicella virus vaccine live 0.5ml. In approximately July 2003, within the last month or two, the patient broke out with chicken pox. It was noted that this was more than a mild case. Unspecified medical attention was sought. There was no product quality complaint involved. The reporter also mentioned other patients and one sibling who experienced a similar reaction with varicella virus vaccine live. Additional information has been requested.
Began with serious bowel event. ER emergency, inflamed bowels and colin.  Severe fever with severe sweating, however always sub temp at 97.3 - 5. Profuse vomiting and diareah.  Very sick until just yester 2.18.19.  I began to feel much better.  I'm scared for second shot tomorrow, but I plan on taking it
My left arm is lame.  Muscle has lumps in it.  Can't use it without pain from day after shot to now. 5/5/08-office notes received for DOS 12/5/07 and 4/11/08- No complains of arm pain.
I am breastfeeding and am postpartum; I am breastfeeding and am postpartum; I had vaginal bleeding, otherwise known as my period.  It lasted for four days and has not returned since April 10th.; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 31Mar2021 at 19:30 (at the age of 35-years-old) as DOSE 2, SINGLE and also received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 10Mar2021 at 12:30 as DOSE1, SINGLE for COVID-19 immunisation. Medical history reported as none. Concomitant medications included post-natal vitamins (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 10Apr2021, at 12:00 after receiving the second dose of vaccine the patient had vaginal bleeding, otherwise known as period, strange thing about this was that patient was breastfeeding and postpartum as of January 1, 2021. It lasted for four days and has not returned since April 10th. No therapeutic measures were taken as a result of reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome for the events were unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021547027 Mother/Baby case
None Stated 04/02/07-records received from facility. Developed rash around injection site, pulse 100, felt shaky, tightness in chest and heart felt like it was racing. Feels anxious, agitated, lightheaded. PE:WNL. DX: Anxiety disorder.
This spontaneous case was reported by a consumer and describes the occurrence of WEIGHT DECREASED (Lost 8 pounds in the last two weeks), PAIN (Aches), URTICARIA (Hives from head to toe), ASTHENIA (Weakness) and DIARRHOEA (Diarrhea a few times) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PAIN (Aches), PYREXIA (Fever) and CHILLS (Chills). On 18-Mar-2021, the patient experienced URTICARIA (Hives from head to toe) and RASH (Rash from head to toe). On an unknown date, the patient experienced WEIGHT DECREASED (Lost 8 pounds in the last two weeks), ASTHENIA (Weakness) and DIARRHOEA (Diarrhea a few times). On 18-Mar-2021, PAIN (Aches), PYREXIA (Fever) and CHILLS (Chills) had resolved. At the time of the report, WEIGHT DECREASED (Lost 8 pounds in the last two weeks), URTICARIA (Hives from head to toe), ASTHENIA (Weakness), DIARRHOEA (Diarrhea a few times) and RASH (Rash from head to toe) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.  Treatment information was not provided.
Dizziness, progressively worse , now starts upon waking up and continuing all day. Previously lost hearing after first vaccine in February of 2021,  abated.  Visited ENT.